Sofinnova Investments, Inc. Q1 2023 Filing
Filed May 11, 2023
Portfolio Value
$1.6T
Holdings
51
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (51 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics Inc | 1,773,124 | $322.1B | 20.60% | |
| 2 | NTRANatera Inc | 3,100,560 | $172.1B | 11.01% | |
| 3 | MRKMerck & Co Inc | 841,522 | $89.5B | 5.73% | |
| 4 | SPYSPDR S&P 500 ETF Trust | 200,000 | $81.9B | 5.24% | Put |
| 5 | ASNDAscendis Pharma A/S | 754,032 | $80.8B | 5.17% | |
| 6 | AVTEAerovate Therapeutics Inc | 3,758,686 | $75.8B | 4.85% | |
| 7 | RETAEURReata Pharmaceuticals Inc | 627,683 | $57.1B | 3.65% | |
| 8 | LLYEli Lilly and Co | 137,100 | $47.1B | 3.01% | |
| 9 | HZNPHorizon Therapeutics PLC | 408,819 | $44.6B | 2.85% | |
| 10 | ISRGIntuitive Surgical Inc | 149,589 | $38.2B | 2.44% | |
| 11 | BIIBBiogen Inc | 132,600 | $36.9B | 2.36% | |
| 12 | BMRNBiomarin Pharmaceutical Inc | 359,035 | $34.9B | 2.23% | |
| 13 | DC4Dexcom Inc | 257,227 | $29.9B | 1.91% | |
| 14 | TVTXTravere Therapeutics Inc | 1,263,721 | $28.4B | 1.82% | |
| 15 | VERAVera Therapeutics Inc | 3,467,156 | $26.9B | 1.72% | |
| 16 | PTCTPTC Therapeutics Inc | 517,095 | $25.0B | 1.60% | |
| 17 | ZNTLZentalis Pharmaceuticals Inc | 1,439,062 | $24.8B | 1.58% | |
| 18 | INBXUSDInhibrx Inc | 1,244,488 | $23.5B | 1.50% | |
| 19 | 290AChinook Therapeutics Inc | 1,002,348 | $23.2B | 1.48% | |
| 20 | SNDXSyndax Pharmaceuticals Inc | 1,075,424 | $22.7B | 1.45% | |
| 21 | OPHTEURIVERIC bio Inc | 905,982 | $22.0B | 1.41% | |
| 22 | IMTXImmatics NV | 3,132,694 | $21.6B | 1.38% | |
| 23 | INZYInozyme Pharma Inc | 3,655,308 | $20.9B | 1.34% | |
| 24 | GONGeron Corp | 8,274,892 | $18.0B | 1.15% | |
| 25 | SRPTSarepta Therapeutics Inc | 119,065 | $16.4B | 1.05% | |
| 26 | EX9Exelixis Inc | 831,243 | $16.1B | 1.03% | |
| 27 | VIRVir Biotechnology Inc | 657,559 | $15.3B | 0.98% | |
| 28 | TCE2Celldex Therapeutics Inc | 419,397 | $15.1B | 0.97% | |
| 29 | —Prometheus Biosciences Inc | 123,842 | $13.3B | 0.85% | |
| 30 | CYTKCytokinetics Inc | 353,796 | $12.5B | 0.80% | |
| 31 | CTIC1USDCTI Biopharma Corp | 2,794,542 | $11.7B | 0.75% | |
| 32 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $11.0B | 0.70% | |
| 33 | AGENEURAgenus Inc | 6,407,457 | $9.7B | 0.62% | |
| 34 | MRNS*Marinus Pharmaceuticals Inc | 1,200,389 | $8.3B | 0.53% | |
| 35 | GRTXGalera Therapeutics Inc | 3,083,712 | $7.9B | 0.50% | |
| 36 | KURAKura Oncology Inc | 616,169 | $7.5B | 0.48% | |
| 37 | AXSMAxsome Therapeutics Inc | 120,896 | $7.5B | 0.48% | |
| 38 | IMGNEURImmunoGen Inc | 1,924,532 | $7.4B | 0.47% | Call |
| 39 | IDYAIDEAYA Biosciences Inc | 453,149 | $6.2B | 0.40% | |
| 40 | —Nucana PLC | 5,599,999 | $5.4B | 0.34% | |
| 41 | RVMDRevolution Medicines Inc | 183,838 | $4.0B | 0.25% | |
| 42 | NXTCNextcure Inc | 2,671,856 | $4.0B | 0.25% | |
| 43 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $3.8B | 0.24% | |
| 44 | KROSKeros Therapeutics Inc | 77,100 | $3.3B | 0.21% | |
| 45 | NVCRNovocure Ltd | 50,000 | $3.0B | 0.19% | Call |
| 46 | —Nucana PLC | 2,400,000 | $2.3B | 0.15% | |
| 47 | —bluebird bio Inc | 672,815 | $2.1B | 0.14% | |
| 48 | PDSBPDS Biotechnology Corp | 142,635 | $877.2M | 0.06% | |
| 49 | —Fusion Pharmaceuticals Inc | 117,099 | $441.5M | 0.03% | |
| 50 | —Synlogic Inc | 574,972 | $363.4M | 0.02% | |
| 51 | ALNYAlnylam Pharmaceuticals Inc | 448 | $89.7M | 0.01% |